Debra Cafaro Sells Over 10,000 Shares of Ventas Stock

Debra Cafaro, the CEO of Ventas, Inc. (NYSE: VTR), has sold 10,322 shares of the company’s stock in a transaction dated January 2, 2024. The shares were sold at an average price of $77.26, resulting in a total value of $797,477.72. Following this sale, Cafaro retains ownership of 1,145,695 shares, which are valued at approximately $88,516,395.70. This transaction represents a 0.89% decrease in her position.

The sale was officially disclosed in a filing with the Securities and Exchange Commission, accessible through their online database.

Current Stock Performance and Financial Metrics

As of Thursday, shares of Ventas opened at $75.68. The company’s stock shows a 50-day simple moving average of $78.22 and a 200-day simple moving average of $71.20. Ventas boasts a market capitalization of $35.55 billion, with a price-to-earnings (P/E) ratio of 145.53 and a beta of 0.78. The firm has a debt-to-equity ratio of 1.01 and a quick ratio of 0.32. Over the past year, Ventas shares have seen a low of $56.91 and a high of $81.89.

In its most recent earnings report on October 29, 2023, Ventas reported earnings per share (EPS) of $0.88, exceeding analysts’ expectations of $0.87. The company generated revenue of $1.49 billion, surpassing forecasts of $1.44 billion. Ventas achieved a return on equity of 2.05% and a net margin of 4.28%. Year-over-year, the firm’s quarterly revenue increased by 20.5% compared to the prior year, where it reported an EPS of $0.80. For the fiscal year 2025, Ventas has set guidance at 3.450-3.480 EPS.

Dividend Announcement and Shareholder Information

Additionally, Ventas recently disclosed a quarterly dividend of $0.48 per share, scheduled for payment on January 15, 2024. Shareholders on record by December 31, 2023, will receive this dividend, with the ex-dividend date also set for December 31. This represents an annualized dividend of $1.92 and a yield of 2.5%, although the company’s payout ratio currently stands at 369.23%.

Recent trading activity shows notable changes in institutional holdings. Vanguard Group Inc. increased its stake in Ventas by 2.5% during the third quarter, now owning 73,598,827 shares valued at approximately $5.15 billion. Similarly, JPMorgan Chase & Co. raised its holdings by 1.3%, now controlling 29,701,300 shares worth around $2.08 billion. Other institutional investors, such as State Street Corp and Geode Capital Management LLC, also increased their positions, reflecting strong institutional interest in Ventas. Overall, institutional and hedge fund investors own 94.18% of the company’s stock.

Analysts have responded positively to Ventas, with several recent upgrades. Jefferies Financial Group reaffirmed a “buy” rating with a target price of $93.00, while KeyCorp raised its price objective from $70.00 to $85.00, maintaining an “overweight” rating. With a consensus rating of “Moderate Buy,” analysts suggest an average target price of $79.81 for Ventas shares.

Ventas, Inc. operates as a real estate investment trust (REIT) specializing in healthcare-related properties. The company focuses on acquiring, owning, and managing a diverse portfolio, including senior housing communities and medical office buildings. Its revenue model combines long-term leases with active asset management, aimed at meeting the real estate needs of the healthcare sector.